Drug Topics
SEPTEMBER 20, 2024
In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.
STAT
SEPTEMBER 20, 2024
A second health worker who cared for a person hospitalized in Missouri with H5N1 bird flu developed mild respiratory symptoms but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC said Missouri health officials didn’t learn that the health worker had symptoms until after the individual had recovered, too late to run a diagnostic test.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 20, 2024
“By encouraging active self-management using health coaching principles, the WalkBack intervention might be able to reduce the prevalence of recurrent low back pain and associated burden on health care systems,” wrote investigators.
Fierce Healthcare
SEPTEMBER 20, 2024
The Federal Trade Commission is suing the titans of the pharmacy benefit manager industry for anticompetitive practices and artificially raising the price of insulin drug prices, the agency announc | As expected for weeks, the Federal Trade Commission is taking legal action against the biggest three PBMs and its related group purchasing organizations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
SEPTEMBER 20, 2024
Stephanie Sober, MD, MSHP, shares insights into the research that led to Opill’s FDA approval and its implications for women’s access to contraception.
STAT
SEPTEMBER 20, 2024
The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that “artificially inflated” the price of insulin and, consequently, impeded patient access to the life-saving treatment. The administrative complaint accused CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx of creating a “perverse” system of rebates that favored
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration. Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so.
Drug Topics
SEPTEMBER 20, 2024
Johnny Garcia, Senior Director of Policy at the Pharmaceutical Care Management Association, discussed the common misconceptions surrounding PBMs and their role within the supply chain.
Pharmacy Times
SEPTEMBER 20, 2024
The rare disease can result in progressive neurological symptoms and organ complications.
Drug Topics
SEPTEMBER 20, 2024
The vaccine will be made available via third-party online pharmacies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
SEPTEMBER 20, 2024
Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.
Drug Topics
SEPTEMBER 20, 2024
Zevra Therapeutics said it expects the therapy to be commercially available in the United States in 8 to 12 weeks.
STAT
SEPTEMBER 20, 2024
Amid a steady rise in research misconduct allegations over the past decade, the Department of Human Health and Services last week updated its guidance on how universities and other institutions investigate claims. It’s a move that experts say is a step in the right direction — though many warn that more systemic change is needed to address mounting concerns over data manipulation and other issues in the sciences.
Pharmacy Times
SEPTEMBER 20, 2024
The decision expands treatment options for patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM).
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 20, 2024
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some psychiatric side effects like anxiety and sleep disturbances — results that pose a challenge to the pharma giant’s efforts to find novel obesity drugs that could extend its success from its blockbuster Wegovy. A Phase 2a trial tested monlunabant, a pill that inhibits CB1 receptors that Novo got through its acquisition of Inversago Pharma last year.
Pharmacy Times
SEPTEMBER 20, 2024
Dermatomal reactions could occur following recombinant zoster vaccine to treat shingles.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration has tapped Ross Segan, a former device industry exec and Army veteran, to lead its division charged with ensuring medical device safety. Segan was chief medical officer at Olympus from 2020 to 2023. Olympus is a leading distributor of endoscopes and the recipient of FDA warning letters claiming the company did not adequately address product defects — including instances where endoscope caps fell into patients’ bodies.
Pharmacy Times
SEPTEMBER 20, 2024
Amivatamab-vmjw is a fully-human bispecific antibody targeting EGFR and MET with immune cell-directed activity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 20, 2024
In 2013, I sat down at my computer and secured the URL t1international.com. I wanted a place where I could collect and share everything I was learning about the global insulin price crisis. I was only 25 years old, and I had already been living with type 1 diabetes for more than two decades. I had struggled with the ups and downs of high and low blood sugars, been hospitalized multiple times, and faced wildly high costs for my insulin and diabetes supplies in the United States.
Pharmacy Times
SEPTEMBER 20, 2024
The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
STAT
SEPTEMBER 20, 2024
Like all living things, cancer cells need to eat, and scientists have long tried to figure out how to starve tumors to death. A lot of that effort has focused on stifling the cells’ ability to digest glucose, a simple sugar thought to be the main food source for cancer. The glucose route has been ineffective, says William Lowry, a biologist at the University of California, Los Angeles.
Pharmacy Times
SEPTEMBER 20, 2024
Improvements in survival outcomes were seen among those at high risk for DLBCL who received 6x R-CHOP21 + 2R.
PharmaVoice
SEPTEMBER 20, 2024
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.
STAT
SEPTEMBER 20, 2024
Amazon is terminating its contract with Progyny, a company that sells fertility benefits such as in vitro fertilization and egg freezing to employers, according to a source familiar with the matter. Starting Jan. 1, 2025, Amazon employees will no longer have access to Progyny’s services. Instead, Amazon will use Maven as its fertility benefits vendor, the person said.
PharmaVoice
SEPTEMBER 20, 2024
A promising epilepsy drug Ovid sold to Takeda recently missed the mark in late-stage trials. But Ovid believes it has other novel mechanisms that could deliver a CNS win.
STAT
SEPTEMBER 20, 2024
In 2012, British journalist Michael Mosley sparked a global trend with his BBC documentary, “Eat, Fast and Live Longer.” Seeking a simple way to get healthy without growing his to-do list, Mosley discovered fasting. “What I discovered was truly surprising — it involves no pills, no injections and no hidden costs. It’s all a matter of what you eat.
Fierce Healthcare
SEPTEMBER 20, 2024
Fabric, formerly known as Florence, continues its acquisition spree, picking up TeamHealth's 50-state virtual care service. | Fabric continues its acquisition spree, picking up TeamHealth's 50-state virtual care service. The deal marks Fabric's fourth acquisition in 18 months and adds TeamHealth's virtual care network to expand access and services across the country and 36 million additional lives.
Pharmacy Times
SEPTEMBER 20, 2024
The chief product and strategy officer at Linus Health is hopeful that pharmacists can be key players in the detection of mild cognitive impairment.
Fierce Healthcare
SEPTEMBER 20, 2024
Cigna is reshaping its Medicare Advantage (MA) plan lineup across eight states, affecting members in 36 health plans. | Cigna is the latest company to rethink its Medicare Advantage offerings, choosing to cut plans in eight states including Florida.
Pharmacy Times
SEPTEMBER 20, 2024
Federal statutes and regulations outline the expectations
STAT
SEPTEMBER 20, 2024
As a pediatrician working for NYC Health + Hospitals (H+H), one of the largest public health care systems in the country, I have witnessed firsthand the challenges of providing quality care to patients from all walks of life. Whether they’re American-born or newly arrived children, my colleagues and I are tasked with ensuring they get the medical attention they need.
Fierce Healthcare
SEPTEMBER 20, 2024
Healthcare supply and services company Cardinal Health has a deal in place to acquire Integrated Oncology Network, a collection of more than 50 community oncology centers, for just over $1.1 billio | The latest deal in a community oncology arms race will bring over 50 practices and 100 providers into Navista, Cardinal's cancer unit.
STAT
SEPTEMBER 20, 2024
WASHINGTON — A federal appeals court ruled that three organizations, including the brand drug lobby PhRMA, can challenge Medicare’s drug price negotiation program in a lower court based in Texas.
Expert insights. Personalized for you.
469 
Let's personalize your content